BR9606528A - Compound salt of a compound process for the preparation of a compound pharmaceutical composition product use of a compound and method for the treatment of a mammal in need of an antineoplastic agent - Google Patents

Compound salt of a compound process for the preparation of a compound pharmaceutical composition product use of a compound and method for the treatment of a mammal in need of an antineoplastic agent

Info

Publication number
BR9606528A
BR9606528A BR9606528A BR9606528A BR9606528A BR 9606528 A BR9606528 A BR 9606528A BR 9606528 A BR9606528 A BR 9606528A BR 9606528 A BR9606528 A BR 9606528A BR 9606528 A BR9606528 A BR 9606528A
Authority
BR
Brazil
Prior art keywords
compound
mammal
preparation
treatment
pharmaceutical composition
Prior art date
Application number
BR9606528A
Other languages
Portuguese (pt)
Inventor
Paolo Cozzi
Italo Beria
Lauro Capolongo
Cristina Franzetti
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of BR9606528A publication Critical patent/BR9606528A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
BR9606528A 1995-07-21 1996-06-19 Compound salt of a compound process for the preparation of a compound pharmaceutical composition product use of a compound and method for the treatment of a mammal in need of an antineoplastic agent BR9606528A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9514993.6A GB9514993D0 (en) 1995-07-21 1995-07-21 Site specific phenyl nitrogen mustards
PCT/EP1996/002659 WO1997003957A1 (en) 1995-07-21 1996-06-19 Bis-(2-haloethyl)aminophenyl substituted distamycin derivatives as antitumor and antiviral agents

Publications (1)

Publication Number Publication Date
BR9606528A true BR9606528A (en) 1997-12-23

Family

ID=10778062

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9606528A BR9606528A (en) 1995-07-21 1996-06-19 Compound salt of a compound process for the preparation of a compound pharmaceutical composition product use of a compound and method for the treatment of a mammal in need of an antineoplastic agent

Country Status (18)

Country Link
EP (1) EP0787126A1 (en)
JP (1) JPH10506410A (en)
KR (1) KR970706251A (en)
CN (1) CN1159183A (en)
AR (1) AR003456A1 (en)
AU (1) AU6357996A (en)
BR (1) BR9606528A (en)
CA (1) CA2199635A1 (en)
EA (1) EA000033B1 (en)
GB (1) GB9514993D0 (en)
HU (1) HUP9702393A3 (en)
IL (1) IL120342A0 (en)
MX (1) MX9701949A (en)
NO (1) NO971142D0 (en)
PL (1) PL319352A1 (en)
TW (1) TW367325B (en)
WO (1) WO1997003957A1 (en)
ZA (1) ZA965028B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6635417B1 (en) 1996-07-31 2003-10-21 California Institute Of Technology Complex formation between DSDNA and oligomer of cyclic heterocycles
WO1998037066A1 (en) 1996-02-26 1998-08-27 California Institute Of Technology Improved polyamides for binding in the minor groove of double stranded dna
US5998140A (en) 1996-07-31 1999-12-07 The Scripps Research Institute Complex formation between dsDNA and oligomer of cyclic heterocycles
GB9623522D0 (en) * 1996-11-11 1997-01-08 Pharmacia & Upjohn Spa Benzoheterocycle distamycin derivatives process for preparing them and their use as antitumour and antiviral agents
GB9816652D0 (en) * 1998-07-30 1998-09-30 Pharmacia & Upjohn Spa Sulfurated distamycin derivatives process for preparing them and their use as antitumor agents
GB9907414D0 (en) 1999-03-31 1999-05-26 Cancer Res Campaign Tech Improvements relating to prodrugs
US6559125B1 (en) 2000-01-28 2003-05-06 California Institute Of Technology Polyamide-alkylator conjugates and related products and method
US20030236198A1 (en) 2001-06-13 2003-12-25 Genesoft, Inc. Antipathogenic benzamide compounds
WO2004012736A1 (en) 2002-08-02 2004-02-12 Genesoft Pharmaceuticals, Inc. Biaryl compounds having anti-infective activity
WO2004039318A2 (en) 2002-10-25 2004-05-13 Genesoft Pharmaceuticals, Inc. Anti-infective biaryl compounds
AU2003297822A1 (en) 2002-12-10 2004-06-30 Oscient Pharmaceuticals Corporation Antibacterial compounds having a (pyrrole carboxamide)-(benzamide)-(imidazole carboxamide) motif
EP2792355A1 (en) 2013-04-17 2014-10-22 Albert-Ludwigs-Universität Freiburg Compounds for use as bromodomain inhibitors
CN115414356A (en) * 2022-09-27 2022-12-02 广西科技大学 Application of indenopyrrole derivatives in preparation of antitumor pharmaceutical composition

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8612218D0 (en) * 1986-05-20 1986-06-25 Erba Farmitalia Site specific alkylating agents

Also Published As

Publication number Publication date
HUP9702393A2 (en) 1998-04-28
ZA965028B (en) 1997-01-23
TW367325B (en) 1999-08-21
JPH10506410A (en) 1998-06-23
EA199700046A1 (en) 1997-12-30
NO971142L (en) 1997-03-12
GB9514993D0 (en) 1995-09-20
AR003456A1 (en) 1998-08-05
CA2199635A1 (en) 1997-02-06
MX9701949A (en) 1997-06-28
PL319352A1 (en) 1997-08-04
CN1159183A (en) 1997-09-10
IL120342A0 (en) 1997-06-10
EA000033B1 (en) 1998-02-26
AU6357996A (en) 1997-02-18
HUP9702393A3 (en) 1998-05-28
EP0787126A1 (en) 1997-08-06
NO971142D0 (en) 1997-03-12
WO1997003957A1 (en) 1997-02-06
KR970706251A (en) 1997-11-03

Similar Documents

Publication Publication Date Title
BR9612204A (en) Compound use of the compound Pharmaceutical composition and process for preparing the compound and for treating pain
BR9602705A (en) Compound pharmaceutical composition process for the preparation of a compound and use
BR9600821A (en) Compound pharmaceutical formulation and process for the preparation of a compound
BR9609780A (en) Compound use of a compound process for the treatment of pharmaceutical composition conditions processes for preparing a pharmaceutical composition and for preparing a compound
BR9503812A (en) Compound pharmaceutical composition use method of treatment of a human process for the preparation of a compound
BR9610988A (en) Composite use of the same pharmaceutical formulation and process for producing the compound
BR9611986A (en) Process compounds for the preparation of the same pharmaceutical composition and use of the compounds
BR9504509A (en) Compound process for its preparation and pharmaceutical formulation
BR9612135A (en) Process taxoids for their preparation and pharmaceutical composition
BR9502555A (en) Composition consisting of a dendrimer and an active substance occluded in the dendrimer process for the preparation of such a composition and process for the release of an active substance
BR1100850A (en) Compound, process for the preparation of a compound, and pharmaceutical composition
BR9501770A (en) Use of a compound, compound, pharmaceutical formulation and process for preparing a compound
BR9508586A (en) Compounds of the same preparation process use the same process of treating a clinical condition in a mammal and pharmaceutical composition
BR9601509A (en) Process compounds for their preparations composition for cosmetic or dermatological use composition in the form of an aqueous dispersion of lipid spherules use of compound and process for cosmetic treatment of moistening
BR9505610A (en) Compound pharmaceutical composition process for the preparation of a compound use and method of treating inflammation and pain
BR9505107A (en) Compound pharmaceutical composition process for the preparation of a compound and its use
BR9603072A (en) Hair treatment agent and process for its preparation
BR9506473A (en) Compound process for the preparation of compounds use of a compound pharmaceutical composition and process for the treatment of anti-fungal infections
BR9606528A (en) Compound salt of a compound process for the preparation of a compound pharmaceutical composition product use of a compound and method for the treatment of a mammal in need of an antineoplastic agent
BR9609327A (en) New oxazolidinone derivatives processes for their preparation and pharmaceutical agents that contain these compounds
BR9600147A (en) Purin-6-ones 2,9-DI-substituted process for its preparation and medication use
BR9610733A (en) Compound processes for the preparation of it and for the treatment of a mammal pharmaceutical composition and use of a compound
PT956054E (en) A process for the vaporization and supercooling of a sterilizing agent and apparatus for its accomplishment
BR9506106A (en) Process compound for its drug preparation and pharmaceutical composition
BR9510417A (en) Composition of alkyl polysaccharide salt from the same process for the preparation of alkyl polysaccharide derivatives and formulation

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law